Approval · Notice of Compliance 214 · 2002
ENTROPHEN: Notice of Compliance 214
Issued March 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 214
- Date
- March 20, 2002
- Company
- Wampole BrandsBoucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Nonsteroidal anti-inflammatory, analgesic agent, platelet aggregation inhibitor
Products in this notice
Medicinal ingredients
- ACETYLSALICYLIC ACID 325 MG per TAB